Skip to content

The Smartlipo Triplex 1440nm Wavelength Laser and the Sidelaze 800 Hand Piece for the Treatment of Facial Acne Scars

The Smartlipo Triplex 1440nm Wavelength Laser and the Sidelaze 800 Hand Piece for the Treatment of Facial Acne Scars

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02103816
Enrollment
21
Registered
2014-04-04
Start date
2013-10-31
Completion date
2015-02-28
Last updated
2020-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Scars

Brief summary

The purpose of this study to evaluate the SmartLipo Triplex laser system along with the SideLaze800 hand piece in the treatment of Acne Scars.

Interventions

DEVICESmartLipo Triplex laser system along with the SideLaze800 hand piece

Sponsors

Cynosure, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* A healthy male or female between 18 and 65 years old * Has unwanted facial acne scars and wishes to undergo laser treatments. * Is willing to consent to participate in the study. * Is willing to comply with all requirements of the study including being photographed, following post treatment care and attending follow up visits.

Exclusion criteria

* The subject is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding or planning a pregnancy during the study period. * The subject is hypersensitive to light exposure OR takes photo sensitized medication. * The subject has active or localized systemic infections. * The subject has a coagulation disorder or is currently using anti-coagulation medication (including but not limited to the heavy use of aspirin) {greater than 81 mg per day}). * The subject is currently enrolled in an investigational drug or device trial, or has received an investigational drug or been treated with an investigational device within the planned treatment area 3 months prior to entering this study. * The subject has used Accutane within 6 months prior to enrollment. * The subject has the need to be exposed to artificial tanning devices or excessive sunlight during the trial. * The subject has had prior treatment with parenteral gold therapy (gold sodium thiomalate). * The subject has a history of keloids. * The subject has evidence of compromised wound healing. * The subject has a history of squamous cell carcinoma or melanoma. * The subject has a history of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications. * The subject has an allergy to lidocaine and epinephrine. * The subject has any condition which, in the investigator's opinion, would make it unsafe for the subject to participate in this research study.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants With Facial Acne Improvement Using the Global Aesthetic Improvement Scale3 months post treatmentThis assesses the level of improvement of acne scarring using the Global Aesthetic Improvement Scale. It is done through using photographic evaluation, comparing the baseline photograph to a photograph taken 3 months post the last treatment. The options for the acne scarring improvement are very much improved, much improved, improved, no change, or worse. The photographic evaluator decides this improvement based off of scar appearance differences amongst the photographs.

Secondary

MeasureTime frameDescription
Investigator Satisfaction Questionnaire3 months post treatmentThe investigator chooses if they are extremely satisfied, satisfied, slightly satisfied, slightly dissatisfied, dissatisfied, or extremely dissatisfied with the results.
Subject Satisfaction Questionnaire3 months post treatmentThe subject chooses if they are extremely satisfied, satisfied, slightly satisfied, slightly dissatisfied, dissatisfied, or extremely dissatisfied with the results.

Countries

United States

Participant flow

Pre-assignment details

One additional patient was enrolled beyond the limitations specified by the original protocol. The protocol was amended (and approved by the IRB) part way through the study to allow for the enrollment of this additional subject.

Participants by arm

ArmCount
SmartLipo Triplex Laser System Along With the SideLaze800 Hand
SmartLipo Triplex laser system along with the SideLaze800 hand piece
21
Total21

Baseline characteristics

CharacteristicSmartLipo Triplex Laser System Along With the SideLaze800 Hand
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
21 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Score I
0 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Score II
0 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Score III
11 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Score IV
7 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Score V
3 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Score VI
0 Participants
Race/Ethnicity, Customized
Race/Ethnicity
African American
2 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Asian
2 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Caucasian
8 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Hispanic
5 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Other
4 Participants
Sex: Female, Male
Female
14 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 21
other
Total, other adverse events
16 / 21
serious
Total, serious adverse events
0 / 21

Outcome results

Primary

Percentage of Participants With Facial Acne Improvement Using the Global Aesthetic Improvement Scale

This assesses the level of improvement of acne scarring using the Global Aesthetic Improvement Scale. It is done through using photographic evaluation, comparing the baseline photograph to a photograph taken 3 months post the last treatment. The options for the acne scarring improvement are very much improved, much improved, improved, no change, or worse. The photographic evaluator decides this improvement based off of scar appearance differences amongst the photographs.

Time frame: 3 months post treatment

Population: 1 subject completed the follow up over the phone, so there is no physician score for this subject. 2 subjects were a no-show for their appointment, but attended the other optional follow ups. The other 4 did not return to follow ups and could not be reached after numerous attempts to follow up.

ArmMeasureGroupValue (NUMBER)
SmartLipo Triplex Laser System Along With the SideLaze800 HandPercentage of Participants With Facial Acne Improvement Using the Global Aesthetic Improvement ScaleVery Much Improved28.6 percentage of participants
SmartLipo Triplex Laser System Along With the SideLaze800 HandPercentage of Participants With Facial Acne Improvement Using the Global Aesthetic Improvement ScaleMuch Improved57.1 percentage of participants
SmartLipo Triplex Laser System Along With the SideLaze800 HandPercentage of Participants With Facial Acne Improvement Using the Global Aesthetic Improvement ScaleImproved14.3 percentage of participants
Secondary

Investigator Satisfaction Questionnaire

The investigator chooses if they are extremely satisfied, satisfied, slightly satisfied, slightly dissatisfied, dissatisfied, or extremely dissatisfied with the results.

Time frame: 3 months post treatment

Population: 1 subject completed the follow up over the phone, so there is no physician score for this subject. 2 subjects were a no-show for their appointment, but attended the other optional follow ups. The other 4 did not return to follow ups and could not be reached after numerous attempts to follow up.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
SmartLipo Triplex Laser System Along With the SideLaze800 HandInvestigator Satisfaction QuestionnaireExtremely Satisfied6 Participants
SmartLipo Triplex Laser System Along With the SideLaze800 HandInvestigator Satisfaction QuestionnaireSatisfied5 Participants
SmartLipo Triplex Laser System Along With the SideLaze800 HandInvestigator Satisfaction QuestionnaireSlightly Satisfied3 Participants
Secondary

Subject Satisfaction Questionnaire

The subject chooses if they are extremely satisfied, satisfied, slightly satisfied, slightly dissatisfied, dissatisfied, or extremely dissatisfied with the results.

Time frame: 3 months post treatment

Population: 2 subjects were a no-show for their appointment, but attended the other optional follow ups. The other 4 did not return to follow ups and could not be reached after numerous attempts to follow up.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
SmartLipo Triplex Laser System Along With the SideLaze800 HandSubject Satisfaction QuestionnaireExtremely Satisfied6 Participants
SmartLipo Triplex Laser System Along With the SideLaze800 HandSubject Satisfaction QuestionnaireSatisfied6 Participants
SmartLipo Triplex Laser System Along With the SideLaze800 HandSubject Satisfaction QuestionnaireSlightly Satisfied2 Participants
SmartLipo Triplex Laser System Along With the SideLaze800 HandSubject Satisfaction Questionnaireslightly dissatisfied1 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026